Skip to main content
SpringerLink
Log in
Book cover

The Detection of New Adverse Drug Reactions pp 1–27Cite as

Introduction

  • Chapter

  • 19 Accesses

Abstract

Adverse drug reactions (ADR) must have started at the dawn of time when man first used plants as medication and learnt to brew alcohol and smoke tobacco. Both Homer (700 BC) and Hippocrates (400 BC) referred to them as problems. The history of ADR before thalidomide has been covered by Penn in Iatrogenic Diseases (see Bibliography).

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Distillers Company (Biochemicals Ltd). Distaval. Lancet, 1961, 2, 1262

    Google Scholar 

  2. Nicholls, J.J. The Practolol Syndrome — a retrospective analysis. In Postmarketing Surveillance of Adverse Reactions to New Medicines. Medico-pharmaceutical Forum, Publication no. 7, 1977

    Google Scholar 

  3. Anon. Thalidomide’s long shadow. Br. Med. J., 1976, 2, 1155

    Google Scholar 

  4. Skegg, D.C.G. and Doll, R. The case for recording events in clinical trials. Br. Med. J., 1977, 2, 1523–1524

    Article  Google Scholar 

  5. Hemminki, L. Study of information submitted by drug companies to licensing authorities. Br. Med. J., 1980, 1, 836

    Google Scholar 

  6. Skegg, D.C.G. Adverse reaction monitoring in the future. In Pharmaceutical Medicine (ed. N. Macleod), Churchill Livingstone, 1979, p.144

    Google Scholar 

  7. Dollery, C.T. Clinical trials of new drugs. J.R. Coll. Physicians Lond., 1977, 11(3), 226–233

    Google Scholar 

  8. Inman, W.H.W. Monitoring by voluntary reporting at national level. In Adverse Drug Reactions (ed. D.J. Richards and R.K. Rondel), Churchill Livingstone, 1972

    Google Scholar 

  9. Inman, W.H.W. and Adelstein, A.M. Rise and fall of asthma mortality in England and Wales in relation to pressurised aerosols. Lancet, 1969, 2, 279

    Article  Google Scholar 

  10. Crooks, J. The detection of adverse drug reactions. J.R. Coll. Physicians Lond., 1977, 11(3), 239–244

    Google Scholar 

  11. Tierney, S. The testing of new drugs and the responsibility for their unforeseen effects. J.R. Coll. Physicians Lond., 1977, 11(3), 237

    Google Scholar 

  12. Beral, V. et al. Mortality among oral contraceptive users. Lancet, 1977, 2, 727–731

    Google Scholar 

  13. Bader, J.-P. Scrip, 1981, No. 639, 1

    Google Scholar 

  14. Schönhöfer, P. Scrip, 1981, No. 638, 2

    Google Scholar 

  15. Melmon, K.L. and Nierenberg, D.W. Drug interactions and the prepared observer. New Engl. J. Med., 1981, 304(12), 723–725

    Article  Google Scholar 

  16. Wright, P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br. Med. J., 1975, 1, 595–598

    Article  Google Scholar 

  17. Herbst, A.L., Ulfelder, H. and Poskanzer, D.C. Association of maternal stilboestrol therapy with tumour appearance in young women. New Engl. J. Med., 1971, 284, 878

    Article  Google Scholar 

  18. Committee of Principal Investigators. A co-operative trial in the primary prevention of ischaemic heart disease using Clofibrate. Br. Heart J., 1978, 40, 1069–1118

    Article  Google Scholar 

  19. Committee of Principal Investigators. WHO co-operative trial on primary prevention of ischaemic heart disease using Clofibrate to lower serum cholestrol: Mortality follow-up. Lancet, 1980, 2, 279–385

    Google Scholar 

  20. Cross. K.W. Cost of preventing retrolental fibroplasia. Lancet, 1973, 2, 954–956

    Article  Google Scholar 

  21. Bolton, D.P.G. and Cross, K.W. Further observations on cost of preventing retrolental fibroplasia. Lancet, 1974, 1, 445–458

    Article  Google Scholar 

  22. Miller, D.L., Ross, E.M., Alderslade, R., Bellman, M.H. and Rawson, N.S.B. Pertussis immunisation and serious acute neurological illness in children. Br. Med. J., 1981, 282(6276), 1565

    Article  Google Scholar 

  23. Meade, T.W. Pertussis vaccine. Br. Med. J., 1981, 283, 59

    Article  Google Scholar 

  24. Anon. Pertussis vaccine. Br. Med. J., 1981, 282(6276), 1563–1564

    Google Scholar 

  25. Fleming, D.M., Knox, J.D.E. and Crombie, D.L. Debendox in early pregnancy and fetal malformation. Br. Med. J., 1981, 283, 99–101

    Article  Google Scholar 

  26. Dinman, B.D. Occupational health and the reality of risk — an eternal dilemma of tragic choice. J. Occup. Med., 1980, 22(3), 153–157

    Google Scholar 

  27. Dinman, B.D. The reality and acceptance of risk. J.A.M.A., 1980, 244(11), 1226–1228

    Article  Google Scholar 

  28. Daily Telegraph. 3 June–25 June 1981

    Google Scholar 

  29. Pochin, E.E. The acceptance of risk. Br. Med. Bull., 31(3), 1975, 184

    Google Scholar 

  30. Porter, J. and Jick, H., Drug-related deaths among medical in-patients. J.A.M.A., 1977, 237, 879

    Article  Google Scholar 

  31. Girdwood, R.H. Deaths after taking medicaments. Br. Med. J., 1974, 1, 501–504

    Article  Google Scholar 

  32. Anon. Hunting rare adverse drug reactions. Br. Med. J., 1981, 282(6261), 342

    Google Scholar 

  33. Inman, W.H.W. Postmarketing surveillance of adverse drug reactions in general practice, I. Br. Med. J., 1981, 282, 1131–1132

    Article  Google Scholar 

  34. Shapiro, S. Postmarketing assessment of drugs. In Post-marketing Surveillance of Adverse Reactions to New Medicines, Medico-pharmaceutical Forum, Publication no. 7, 1977

    Google Scholar 

  35. Lewis, J.A. Postmarketing surveillance: How many patients? Trends Pharmacol. Sci., 1981, 2(4), 93–94

    Article  Google Scholar 

  36. Anon. Rauwolfia and breast cancer. Lancet, 1975, 2, 312

    Google Scholar 

  37. Spriet-Pourra, C., Spriet, A., Soubrie, C. and Simon, P. Les méthodes d’étude des effets indésirables des médicaments, II: Thérapie, 1982, 37, 13–22

    Google Scholar 

  38. Finney, D.J. The design and logic of a monitor of drug use. J. Chron. Dis., 1965, 18, 77–98

    Article  Google Scholar 

  39. Inman, W.H.W. Postmarketing surveillance of adverse drug reactions in general practice, II. Br. Med. J., 1981, 282

    Google Scholar 

  40. Karch, F.E. and Lasagna, L. Adverse drug reactions. J.A.M.A., 1975, 234(12), 1236

    Article  Google Scholar 

  41. Division of Drug Experience, Food and Drug Administration. Procedural Manual for Handling Drug Experience Reports. Glossary, Paper flow and Algorithms, 1980

    Google Scholar 

  42. Kramer, M.S., Leventhal, J.M., Hutchinson, T.A. and Feinstein, A.R. An algorithm for the operational assessment of adverse drug reactions, I: Background, description for use and instruction. J.A.M.A., 1979, 242(7), 623–632

    Article  Google Scholar 

  43. Weintraub, M. Recording events in clinical trials. Br. Med. J., 1978, i, 581

    Article  Google Scholar 

  44. Simpson, R.J., Tiplady, B. and Skegg, D.C.G. Event recording in a clinical trial of a new medicine. Br. Med. J., 1980, 280, 1133–1134

    Article  Google Scholar 

  45. Anon. Lessons from the benoxaprofen affair. Lancet, 1982, 529

    Google Scholar 

  46. Seventh European Symposium on Clinical Pharmacological Evaluation in Drug Control, Deidesheim, 1978. WHO Euro Reports and Studies, WHO, Copenhagen, 13

    Google Scholar 

  47. Rawlins, M.D. and Thompson, J.W. Pathogenesis of adverse drug reactions. In Textbook of Adverse Drug Reactions (ed. D.M. Davies), Oxford University Press, 1977, pp. 10–31

    Google Scholar 

  48. Venulet, J. Monitoring adverse reactions to drugs. In Progress in Drug Research (ed. E. Jucken), Berghausen Verlag, Basle, 1977

    Google Scholar 

  49. Péré, J.C., Bégaud, B., Haramburu, F. and Albin, H. Notions de fréquence et de gravité des effets indésirables. Thérapie, 1984, 447–452

    Google Scholar 

  50. Enstellung von Monographie-Entwürfen. Pharm Ind., 1986, 48 (11a), 1293

    Google Scholar 

  51. Toogood, J.H. What do we mean by ‘usually’? Lancet, 1980, i, 1094

    Article  Google Scholar 

  52. Marion, M.H. and Simon, P. Signification des adverbes utilisés pour indiquer la fréquence des effets secondaires d’un médicament. Thérapie, 1984, 39, 47–63

    Google Scholar 

  53. Bennett, B.S. and Lipman, A.G. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am. J. Hosp. Pharm., 1977, 34, 931–936

    Google Scholar 

  54. Reidenberg, M.M. and Lowenthal, D.T. Adverse non-drug reactions. New Engl. J. Med., 1968, 279(13), 678–679

    Article  Google Scholar 

  55. Bulpitt, C.J., Dollery, C.T. and Carne, S. A symptom questionnaire for hypertensive patients. J. Chron. Dis., 1974, 27, 309–323

    Article  Google Scholar 

  56. Bulpitt, C.J., Dollery, C.T. and Carne, S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br. Heart J., 1976, 38, 121–128

    Article  Google Scholar 

  57. Joubert, P.H., Van Rijssen, F.W.J. and Venter, J.P. Drug side effects assessed in a ‘naturalistic’ setting. S. Afr. Med. J., 1977, 52, 34–36

    Google Scholar 

  58. Joyce, C.R.B. Placebos and other comparative treatments. Br. J. Clin. Pharmacol., 1982, 13, 313–318

    Article  Google Scholar 

  59. Pogge, R.C. The toxic placebo. Med. Times, 1965, 91(8), 773–776

    Google Scholar 

  60. Wolf, S. Placebos. Ass. Res. Nerv. Dis. Proc., 1959, 37, 147–161

    Google Scholar 

  61. Wolf, S. Effects of suggestions and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos. J. Clin. Invest., 1950, 29, 100

    Article  Google Scholar 

  62. Wolf, S. and Pinsky, R.H. Effects of placebo administration and occurrence of toxic reactions. J.A.M.A., 1954, 155, (4), 339–341

    Article  Google Scholar 

  63. Vinar, O. Dependence on a placebo: a case report. Br. J. Psychiat., 1969, 115, 1189–1190

    Article  Google Scholar 

  64. Domecq, C., Naranjo, C.A., Ruiz, I. and Busto, U. Sex-related variations in the frequency and characteristics of adverse drug reactions. J. Clin. Pharmacol. Ther. Toxicol., 1980, 18(8), 362–366

    Google Scholar 

  65. Green, D.M. Pre-existing conditions, placebo reactions and ‘side effects’. Ann. Intern. Med., 1964, 60(2), 255–265

    Article  Google Scholar 

  66. Letemendia, F.J.J. and Harris, A.D. The influence of side effects on the reporting of symptoms. Psychopharmacologia, 1959, 1, 39–17

    Article  Google Scholar 

  67. Wolf, S. The pharmacology of placebos. Pharmacol. Rev., 1959, 11, 689

    Google Scholar 

  68. Tucker, W.B. Effects of placebo administration and occurrence of toxic reactions, J.A.M.A., 1954, 155, 339

    Article  Google Scholar 

  69. Thompson, R. Side effects and placebo amplification. Brit. J. Psychiat., 1982, 140, 64–68

    Article  Google Scholar 

  70. Lasagna, L., Mosteller, F., Von Felsinger, J.M. and Beecher, H.K. A study of placebo response. Am. J. Med., 1954, 16, June, 770–779

    Article  Google Scholar 

  71. Knowles, J.B. and Lucas, C.J. Experimental studies of the placebo response. J. Ment. Sci., 1960, 106, 231–240

    Google Scholar 

  72. Beecher, H.K. The powerful placebo. J.A.M.A., 1955, 159, Dec, 1602–1606

    Article  Google Scholar 

  73. Lasagna, L., Laties, V.G. and Dohan, J.L. Further studies on the ‘pharmacology’ of placebo administration. J. Clin. Invest., 1958, 37, 533–537

    Article  Google Scholar 

  74. Fields, H.L. and Levine, J.D. Biology of placebo analgesia. Am. J. Med., 1981, 70(4), 745–746

    Article  Google Scholar 

  75. Levine, J.D., Gordon, N.C. and Fields, H.L. The mechanism of placebo analgesia. Lancet, 1978, 23, 654–657

    Article  Google Scholar 

  76. Leader. Lancet 1983, ii, 624

    Google Scholar 

  77. Posner, J., Burke, C.A. The effects of Naloxone on opiate and placebo analgesia in healthy volunteers. Psychopharmacology, 1985, 87, 468–472

    Article  Google Scholar 

  78. McDonald, C.J., Mazzuca, S.A. How much of the placebo effect is really statistical regression. Statistics in Medicine, 1983, 2, 417–427

    Article  Google Scholar 

  79. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New Engl. J. Med., 1981, 304(14), 801–807

    Article  Google Scholar 

  80. Schindel, L. Placebo-induced side effects. In Drug Induced Diseases (ed. L. Meyler and H.M. Peck), Excerpta Medica, Amsterdam

    Google Scholar 

Download references

Authors
  1. M. D. B. Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 1988 M.D.B. Stephens

About this chapter

Cite this chapter

Stephens, M.D.B. (1988). Introduction. In: The Detection of New Adverse Drug Reactions. Palgrave, London. https://doi.org/10.1007/978-1-349-09887-3_1

Download citation

Publish with us

Policies and ethics

Search

Navigation